GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cara Therapeutics Inc (FRA:69C0) » Definitions » Inventories, Raw Materials & Components

Cara Therapeutics (FRA:69C0) Inventories, Raw Materials & Components : €2.03 Mil (As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Cara Therapeutics Inventories, Raw Materials & Components?

Cara Therapeutics's inventories, raw materials & components for the quarter that ended in Dec. 2024 was €2.03 Mil.

Cara Therapeutics's quarterly raw materials declined from Jun. 2024 (€1.97 Mil) to Sep. 2024 (€1.91 Mil) but then increased from Sep. 2024 (€1.91 Mil) to Dec. 2024 (€2.03 Mil).

Cara Therapeutics's annual raw materials increased from Dec. 2022 (€1.81 Mil) to Dec. 2023 (€2.42 Mil) but then declined from Dec. 2023 (€2.42 Mil) to Dec. 2024 (€2.03 Mil).


Cara Therapeutics Inventories, Raw Materials & Components Historical Data

The historical data trend for Cara Therapeutics's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cara Therapeutics Inventories, Raw Materials & Components Chart

Cara Therapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 0.82 1.81 2.42 2.03

Cara Therapeutics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.42 1.97 1.97 1.91 2.03

Cara Therapeutics Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


Cara Therapeutics Business Description

Industry
Traded in Other Exchanges
Address
400 Atlantic Street, Suite 500, Stamford, CT, USA, 06901
Cara Therapeutics Inc is a development-stage biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features.

Cara Therapeutics Headlines

No Headlines